High-Resolution Melting Analysis of Sequence Variations in the Cytidine Deaminase Gene (CDA) in Patients With Cancer Treated With Gemcitabine
Authors:
- Joseph CiccoliniJoseph Ciccolini
- Cédric MercierCMCédric Mercier
- Jean-Christophe BoyerJBJean-Christophe Boyer
- Anne PolgeAPAnne Polge
- Benjamin LallemantBLBenjamin Lallemant
- Kévin MouzatKMKévin Mouzat
- Serge LumbrosoSLSerge Lumbroso
- Jean-Paul BrouilletJBJean-Paul Brouillet
- Alexandre EvrardAEAlexandre Evrard
- 1 February 2010
- journal article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 32 (1) , 53-60
Abstract
Gemcitabine (2',2'-difluorodeoxycytidine) is a major antimetabolite cytotoxic drug with a wide spectrum of activity against solid tumors. Hepatic elimination of gemcitabine depends on a catabolic pathway through a deamination step driven by the enzyme cytidine deaminase (CDA). Severe hematologic toxicity to gemcitabine was reported in patients harboring genetic polymorphisms in CDA gene. High-resolution melting (HRM) analysis of polymerase chain reaction amplicon emerges today as a powerful technique for both genotyping and gene scanning strategies. In this study, 46 DNA samples from gemcitabine-treated patients were subjected to HRM analysis on a LightCycler 480 platform. Residual serum CDA activity was assayed as a surrogate marker for the overall functionality of this enzyme. Genotyping of three well-described single nucleotide polymorphisms in coding region (c.79A>C, c.208G>A and c.435C>T) was successfully achieved by HRM analysis of small polymerase chain reaction fragments, whereas unknown single nucleotide polymorphisms were searched by a gene scanning strategy with longer amplicons (up to 622 bp). The gene scanning strategy allowed us to find a new intronic mutation c.246+37G>A in a female patient displaying marked CDA deficiency and who had an extreme toxic reaction with a fatal outcome to gemcitabine treatment. Our work demonstrates that HRM-based methods, owing to their simplicity, reliability, and speed, are useful tools for diagnosis of CDA deficiency and could be of interest for personalized medicine.Keywords
This publication has 37 references indexed in Scilit:
- Diagnostic method validation: High resolution melting (HRM) of small amplicons genotyping for the most common variants in the MTHFR geneClinical Biochemistry, 2009
- Identification of fibrillin-1 gene mutations in Marfan syndrome by high-resolution melting analysisAnalytical Biochemistry, 2009
- Influencing factors of dsDNA dye (high-resolution) melting curves and improved genotype call based on thermodynamic considerationsAnalytical Biochemistry, 2009
- Direct Genotyping of Single Nucleotide Polymorphisms in Methyl Metabolism Genes Using Probe-Free High-Resolution Melting AnalysisCancer Epidemiology, Biomarkers & Prevention, 2008
- Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 SystemAnalytical Biochemistry, 2008
- Scanning the Cystic Fibrosis Transmembrane Conductance Regulator Gene Using High-Resolution DNA Melting AnalysisClinical Chemistry, 2007
- Identifying Common Genetic Variants by High-Resolution MeltingClinical Chemistry, 2007
- Amplicon DNA Melting Analysis for Mutation Scanning and Genotyping: Cross-Platform Comparison of Instruments and DyesClinical Chemistry, 2006
- Genotyping of Single-Nucleotide Polymorphisms by High-Resolution Melting of Small AmpliconsClinical Chemistry, 2004
- High-Resolution Genotyping by Amplicon Melting Analysis Using LCGreenClinical Chemistry, 2003